Markers and measures of timeliness of cancer diagnosis after symptom onset: A conceptual framework and its implications

Cancer Epidemiology

Volumn 38, Issue 3, 2014, Pages 211-213

  Lyratzopoulos, Georgios ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cancer; Diagnosis; Early; Emergency; Interval; Late; Patient; Primary care; Stage; Survival

Indexed keywords

CANCER DIAGNOSIS; CANCER SURVIVAL; CONCEPTUAL FRAMEWORK; DELAYED DIAGNOSIS; DISEASE MARKER; EARLY DIAGNOSIS; HUMAN; NOTE; PATIENT SAFETY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SECONDARY HEALTH CARE; SHORT TERM SURVIVAL; SYMPTOM; CANCER STAGING; EARLY CANCER DIAGNOSIS; ENGLAND; NEOPLASMS; PROCEDURES; STANDARDS; TIME FACTOR;

EARLY DETECTION OF CANCER; ENGLAND; HUMANS; NEOPLASM STAGING; NEOPLASMS; TIME FACTORS;

EID: 84900469892     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2014.03.009     Document Type: Note

References (37)

1. Elliss-Brookes L., McPhail S., Ives A., Greenslade M., Shelton J., Hiom S., et al. Routes to diagnosis for cancer - determining the patient journey using multiple routine data sets. Br J Cancer 2012, 107(8):1220-1226.
2. Department of Health Improving outcomes: a strategy for cancer 2011, http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_123371 [last accessed November 2013].
3. Health Service Circular.HSC 1999/205 Cancer waiting times. Achieving the two week target 1999, http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4012119.pdf.
4. National Institute for Health and Care Excellence (NICE) Clinical Guidelines 27. Referral for suspected cancer 2005, http://www.nice.org.uk/cg027 [last accessed January 2014].
5. Prades J., Espinas J.A., Font R., Argimon J.M., Borras J.M. Implementing a cancer fast-track programme between primary and secondary care in Catalonia (Spain): a mixed methods study. Br J Cancer 2011, 105(6):753-759.
6. New South Wales Government Cancer plan 2011-15 2011, http://www.cancerplan.cancerinstitute.org.au/ [last accessed January 2014].
7. Olesen F., Hansen R.P., Vedsted P. Delay in diagnosis: the experience in Denmark. Br J Cancer 2009, 101(Suppl. 2):S5-S8.
8. Cancer Care Ontario Diagnostic assessment programs: an environmental scan 2009, https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=64068 [last accessed January 2014].
9. The Scottish Government Detect Cancer Early 2012, http://www.scotland.gov.uk/Topics/Health/Services/Cancer/Detect-Cancer-Early [last accessed January 2014].
10. Olesen F., Hansen R.P., Vedsted P. Delay in diagnosis: the experience in Denmark. Br J Cancer 2009, 101(Suppl. 2):S5-S8.
11. Richards M.A. The size of the prize for earlier diagnosis of cancer in England. Br J Cancer 2009, 101(Suppl. 2):S125-S129.
12. Richards M.A., Westcombe A.M., Love S.B., Littlejohns P., Ramirez A.J. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 1999, 353(9159):1119-1126.
13. Tørring M.L., Frydenberg M., Hamilton W., Hansen R.P., Lautrup M.D., Vedsted P. Diagnostic interval and mortality in colorectal cancer: U-shaped association demonstrated for three different datasets. J Clin Epidemiol 2012, 65(6):669-678.
14. Hollenbeck B.K., Dunn R.L., Ye Z., Hollingsworth J.M., Skolarus T.A., Kim S.P., et al. Delays in diagnosis and bladder cancer mortality. Cancer 2010, 116(22):5235-5242.
15. Tørring M.L., Frydenberg M., Hansen R.P., Olesen F., Vedsted P. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care. Eur J Cancer 2013, 49(9):2187-2198.
16. Weller D., Vedsted P., Rubin G., Walter F.M., Emery J., Scott S., et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer 2012, 106(7):1262-1267.
17. National Patient Safety Agency Delayed diagnosis of cancer: thematic review 2010, http://www.nrls.npsa.nhs.uk/resources/?EntryId45=69894.
18. McPhail S., Elliss-Brookes L., Shelton J., Ives A., Greenslade M., Vernon S., et al. Emergency presentation of cancer and short-term mortality. Br J Cancer 2013, 109(8):2027-2034.
19. Lyratzopoulos G., Abel G.A., McPhail S., Neal R.D., Rubin G.P. Measures of promptness of cancer diagnosis in primary care: secondary analysis of national audit data on patients with 18 common and rarer cancers. Br J Cancer 2013, 108(3):686-690.
20. Quaife S.L., Forbes L.J., Ramirez A.J., Brain K.E., Donnelly C., Simon A.E., et al. Recognition of cancer warning signs and anticipated delay in help-seeking in a population sample of adults in the UK. Br J Cancer 2014, 110(1):12-18.
21. Simon A.E., Waller J., Robb K., Wardle J. Patient delay in presentation of possible cancer symptoms: the contribution of knowledge and attitudes in a population sample from the United Kingdom. Cancer Epidemiol Biomarkers Prev 2010, 19(9):2272-2277.
22. Beeken R.J., Simon A.E., von Wagner C., Whitaker K.L., Wardle J. Cancer fatalism: deterring early presentation and increasing social inequalities?. Cancer Epidemiol Biomarkers Prev 2011, 20(10):2127-2131.
23. Scott S.E., Walter F.M., Webster A., Sutton S., Emery J. The model of pathways to treatment: conceptualization and integration with existing theory. Br J Health Psychol 2013, 18(1):45-65.
24. Forbes L.J., Simon A.E., Warburton F., Boniface D., Brain K.E., Dessaix A., et al. International Cancer Benchmarking Partnership Module 2 Working Group. Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival?. Br J Cancer 2013, 108(2):292-300.
25. Brewster D.H., Clark D.I., Stockton D.L., Munro A.J., Steele R.J. Characteristics of patients dying within 30 days of diagnosis of breast or colorectal cancer in Scotland, 2003-2007. Br J Cancer 2011, 104(1):60-67.
26. Maringe C., Walters S., Rachet B., Butler J., Fields T., Finan P., et al. ICBP Module 1 Working Group. Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000-2007. Acta Oncol. 2013, 52(5):919-932.
27. Walters S., Maringe C., Butler J., Rachet B., Barrett-Lee P., Bergh J., et al. ICBP Module 1 Working Group. Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study\. Br J Cancer 2013, 108(5):1195-1208.
28. Walters S., Maringe C., Coleman M.P., Peake M.D., Butler J., Young N., et al. ICBP Module 1 Working Group. Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007. Thorax 2013, 68(6):551-564.
29. Rachet B., Ellis L., Maringe C., Chu T., Nur U., Quaresma M., et al. Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. Br J Cancer 2010, 103(4):446-453.
30. Møller H., Sandin F., Bray F., Klint A., Linklater K.M., Purushotham A., et al. Breast cancer survival in England, Norway and Sweden: a population-based comparison. Int J Cancer 2010, 127(11):2630-2638.
31. Holmberg L., Sandin F., Bray F., Richards M., Spicer J., Lambe M., et al. National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up. Thorax 2010, 65(5):436-441.
32. Lyratzopoulos G., Neal R.D., Barbiere J.M., Rubin G.P., Abel G.A. Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England. Lancet Oncol 2012, 13(4):353-365.
33. Lyratzopoulos G., Elliott M.N., Barbiere J.M., Staetsky L., Paddison C.A., Campbell J., et al. How can health care organizations be reliably compared? Lessons from a national survey of patient experience. Med Care 2011, 49(8):724-733.
34. Ellis L., Rachet B., Coleman M.P. Cancer survival indicators by cancer network: a methodological perspective. Health Stat Q 2007, Winter(36):36-41.
35. Lyratzopoulos G., Abel G.A., Brown C.H., Rous B.A., Vernon S.A., Roland M., et al. Socio-demographic inequalities in stage of cancer diagnosis: evidence from patients with female breast, lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancer. Ann Oncol 2013, 24(3):843-850.
36. Lyratzopoulos G., Abel G. Earlier diagnosis of breast cancer: focusing on symptomatic women. Nat Rev Clin Oncol 2013, 10(9).
37. Keeble S., Abel G.A., Saunders C.L., McPhail S., Walter F.M., Neal R.D., et al. Variation in promptness of presentation among 10,297 patients subsequently diagnosed with one of 18 cancers: evidence from a national audit of cancer diagnosis in primary care. Int J Cancer 2014, (11(February)). [Epub ahead of print]. 10.1002/ijc.28763.